Literature DB >> 16837909

Analysis of RAD51 polymorphism and BRCA1 mutations in Polish women with breast cancer.

H Romanowicz-Makowska1, B Smolarz, M Zadrozny, A Kulig.   

Abstract

AIM: Breast cancer is one of the major killers worldwide. The objectives of this study were to determine the frequency of BRCA1 germ-line mutations and the RAD51 G/C polymorphism in patients with breast cancer.
METHODS: 100 breast cancer women provided blood for mutation analysis. Blood samples age matched healthy individuals (n = 106) served as control. The G/C polymorphism and BRCA1 mutations were determined by PCR-RFLP methods.
RESULTS: The distribution of the genotypes of the G/C polymorphism RAD51 in both control and patients did not differ significantly from those predicted by the Hardy - Weinberg distribution. There were no significant differences in the genotype distributions and allele frequencies between node-positive and node-negative patients. In present study one Ex20insC mutations of BRCA1 gene was identified in women with breast cancer.
CONCLUSION: Our study implies that the G/C polymorphism of the RAD51 gene may not be directly involved in the development and=or progression of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16837909

Source DB:  PubMed          Journal:  Exp Oncol        ISSN: 1812-9269


  8 in total

1.  On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations.

Authors:  Nancy Hamel; Bing-Jian Feng; Lenka Foretova; Dominique Stoppa-Lyonnet; Steven A Narod; Evgeny Imyanitov; Olga Sinilnikova; Laima Tihomirova; Jan Lubinski; Jacek Gronwald; Bohdan Gorski; Thomas v O Hansen; Finn C Nielsen; Mads Thomassen; Drakoulis Yannoukakos; Irene Konstantopoulou; Vladimir Zajac; Sona Ciernikova; Fergus J Couch; Celia M T Greenwood; David E Goldgar; William D Foulkes
Journal:  Eur J Hum Genet       Date:  2010-12-01       Impact factor: 4.246

2.  Genetic 135G/C polymorphism of RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls.

Authors:  Bei-Bei Zhang; Dao-Gang Wang; Chao Xuan; Gui-Li Sun; Kai-Feng Deng
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

3.  Association between RAD51 polymorphism and breast cancer susceptibility: a meta analysis.

Authors:  Wei Li; Ke-Jia Liu; Jing-Song Song; Rui Song; Zi-Liang Liu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

4.  Susceptibility of XPD and RAD51 genetic variants to carcinoma of urinary bladder in North Indian population.

Authors:  Ranbir Chander Sobti; Saranjeet Kaur; Vijay Lakshmi Sharma; Shrawan Kumar Singh; Seyed Ali Hosseini; Rupinder Kler
Journal:  DNA Cell Biol       Date:  2011-07-08       Impact factor: 3.311

5.  RAD51 polymorphisms and breast cancer risk.

Authors:  Mojgan Hosseini; Massoud Houshmand; Ahmad Ebrahimi
Journal:  Mol Biol Rep       Date:  2012-10-13       Impact factor: 2.316

6.  RAD51 135G>C substitution increases breast cancer risk in an ethnic-specific manner: a meta-analysis on 21,236 cases and 19,407 controls.

Authors:  Deepa Sekhar; Singh Pooja; Sandeep Kumar; Singh Rajender
Journal:  Sci Rep       Date:  2015-06-25       Impact factor: 4.379

7.  Association between the RAD51 135 G>C polymorphism and risk of cancer: a meta-analysis of 19,068 cases and 22,630 controls.

Authors:  Wei Wang; Jia-Lin Li; Xiao-Feng He; An-Ping Li; Yong-Lin Cai; Na Xu; Shu-Mei Sun; Bing-Yi Wu
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

8.  Relationship between Rad51 G135C and G172T variants and the susceptibility to cancer: a meta-analysis involving 54 case-control studies.

Authors:  Mengmeng Zhao; Pin Chen; Yanbin Dong; Xianji Zhu; Xilong Zhang
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.